Allarity Therapeutics Files 8-K
Ticker: ALLR · Form: 8-K · Filed: Mar 7, 2025 · CIK: 1860657
Sentiment: neutral
Topics: 8-K, filing, regulatory
Related Tickers: ALLR
TL;DR
ALLARITY THERAPEUTICS (ALLR) FILED AN 8-K ON MARCH 7TH - CHECK FOR UPDATES.
AI Summary
Allarity Therapeutics, Inc. filed an 8-K on March 7, 2025, reporting an "Other Events" and "Financial Statements and Exhibits" filing as of March 6, 2025. The company, incorporated in Delaware with its principal executive offices in Boston, MA, is in the pharmaceutical preparations industry.
Why It Matters
This filing indicates a routine update or disclosure from Allarity Therapeutics, Inc. to the SEC, which may contain important information for investors.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for reporting events and exhibits, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- Allarity Therapeutics, Inc. (company) — Registrant
- March 6, 2025 (date) — Date of earliest event reported
- March 7, 2025 (date) — Filing Date
- Boston, MA (location) — Principal executive offices
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
What financial statements or exhibits are being filed with this 8-K?
The filing lists 'Financial Statements and Exhibits' as an item information, but the specific contents are not detailed in the provided text.
When was the earliest event reported in this filing?
The earliest event reported was on March 6, 2025.
What is Allarity Therapeutics, Inc.'s Standard Industrial Classification code?
The SIC code for Allarity Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Where are Allarity Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 24 School Street, 2nd Floor, Boston, MA 02108.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 7, 2025 regarding Allarity Therapeutics, Inc. (ALLR).